Discover Atai Life Sciences N.V.'s 275% YTD surge, driven by innovative psychedelic therapies for TRD. Click for my ATAI ...

Life is a constant flow of change, and it certainly never seems to stop giving out lemons. Whether we experience celebration, ...

A new study suggests that a well-formulated ketogenic diet, followed for at least 10 weeks, is associated with a significant ...

AjD Represents an Area of Significant Unmet Need; No U.S. Food and Drug Administration(FDA)-Approved Therapies Available ---- Following ...

A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some ...

Objective: To validate a risk rating scale for triaging of cancer patients in emergency rooms that can identify individuals needing urgent care or in imminent worsening of the clinical condition.

Personalized high-definition transcranial direct current stimulation is linked to improved outcomes in moderate-to-severe ...

Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with ...

An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an ...

Depression symptoms and reduced lung function are common among individuals exposed to the August 2023 Maui wildfires.

SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative therapies, today announced that results from its ...

A new long-term follow-up study has found that a significant majority of individuals treated for major depressive disorder with psilocybin-assisted therapy were still in remission from their ...